Clinical Trials Directory

Trials / Completed

CompletedNCT00577928

Value of Fecal Calprotectin

Correlation of Fecal Calprotectin Level With the Clinical, Endoscopic, Histologic and Radiologic Activity in Inflammatory Bowel diseaseThe Value of Fecal Calprotectin for the Diagnosis and Assessment of Inflammatory Bowel Disease

Status
Completed
Phase
Study type
Observational
Enrollment
171 (actual)
Sponsor
Indiana University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

For the main goal - the accuracy of calprotectin for the diagnosis of IBD - calprotectin levels will be compared between patients with and without a diagnosis of IBD and the sensitivity, specificity and accuracy will be determined. For the secondary aim - the correlation between calprotectin levels and disease activity - in patients with IBD selected from this cohort, we will determine the association between calprotectin levels and clinical IBD score, serological markers (WBC, Hgb, Platelets, ESR, CRP, Albumin), endoscopic (disease score, pathological activity) and radiological features (bowel wall thickening, enhancement, edema, mesenteric inflammation).

Conditions

Timeline

Start date
2006-04-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2007-12-20
Last updated
2015-08-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00577928. Inclusion in this directory is not an endorsement.